- Enter the number of events and the matching exposure days (catheter-days for catheter infections, access-days for all accesses). The definition must match the denominator.
- Choose the event definition. Catheter-related bloodstream infection (CRBSI), all bloodstream infection (BSI), and surveillance access-related BSI are different events and are not interchangeable.
- Read the rate per 1,000 days with its exact 95% confidence interval. Zero events give a rate of zero with a real, nonzero upper bound.
- Use the scenario panel to see what a published trial’s rates would mean in absolute numbers over your unit’s catheter-days.
All computation runs in your browser; no values are stored or transmitted.
When to Use
For facility quality review: monthly or quarterly infection rates, before-and-after comparisons, and teaching. It is a unit metric, not an individual patient’s infection risk. Do not convert patient-month surveillance rates casually into catheter-day rates; reporting systems such as the National Healthcare Safety Network (NHSN) use their own definitions.
Access Infection Rate with Exact 95% CI
⚕ Rate = events ÷ exposure days × 1,000. Exact (Garwood) Poisson interval computed by bisection on the Poisson distribution; verified against chi-square quantiles from SciPy for 0, 1, 3, 9, 32, and 100 events.
Constant-rate scenario (published trial rates)
Default rates are from LOCK IT-100: 0.46 per 1,000 catheter-days with heparin and 0.13 with taurolidine/heparin. Edit them for your own baseline. This is a planning illustration that assumes a constant rate; it is not a forecast and does not assume the trial hazard ratio applies to your unit.
Absolute versus relative effect (binary outcomes)
For trials reporting the proportion with an event over the same fixed horizon in each arm. Not valid for Kaplan–Meier patency estimates, rates per patient-day, odds ratios, or hazard ratios.
Formula & Evidence
| Quantity | Formula |
|---|---|
| Rate per 1,000 days | events ÷ exposure days × 1,000 |
| Exact 95% CI (k events) | lower = μ where P(X ≥ k) = 0.025; upper = μ where P(X ≤ k) = 0.025; divide by days × 1,000 |
| Scenario events | rate × catheter-days ÷ 1,000 |
| Absolute risk reduction (ARR) | control risk − treatment risk; number needed to treat (NNT) = ceil(1 ÷ ARR) only when ARR > 0 |
LOCK IT-100: 795 adults dialyzing via catheter at 70 United States sites; CRBSI 0.13 versus 0.46 per 1,000 catheter-days; hazard ratio 0.29 (95% CI 0.14–0.62). The 71% figure is a relative hazard reduction, not an absolute one. Apixaban after thrombectomy (186 patients, open label): recurrent thrombosis 24.0% versus 40.8% at 3 months; minor bleeding 22.6% versus 7.5%. FAVOURED: fistula failure 128/270 (47.4%) with fish oil versus 125/266 (47.0%) with placebo.
